DAVINA DUBE: Open Payments
NPI 1992311195 · NEW MILFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,385 in 100 payments from 15 companies in 2025. Trend: 2023 $46 · 2024 $618 · 2025 $2,385
Food & beverage: $2,375Education: $10
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 19 | $535 |
| ABBVIE INC. | 15 | $410 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $266 |
| Madrigal Pharmaceuticals | 9 | $237 |
| Ardelyx, Inc. | 12 | $212 |
| Aimmune Therapeutics, Inc. | 4 | $108 |
| Phathom Pharmaceuticals, Inc. | 8 | $108 |
| Gilead Sciences, Inc. | 4 | $105 |
| VIVUS LLC | 4 | $100 |
| Celltrion USA Inc. | 3 | $70 |
Products named: TREMFYA, REZDIFFRA, IBSRELA, ENTYVIO, SKYRIZI, ZENPEP, VOQUEZNA, PANCREAZE.
Industry payments across CT — which companies pay providers there.
